PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

NCT05723510 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tegoprazan 50mg
DRUG: Edoxaban 60mg
DRUG: Apixaban 5mg
DRUG: Rivaroxaban 20mg

Sponsor

HK inno.N Corporation